Skip to content
10-K

Annual Report

TENAYA THERAPEUTICS, INC. TNYA

0001193125-26-102252

← back to feed
Filed
Mar 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 5, 2026 217M sh
Shares Diluted FY 2025 · Dec 31, 2025 152.97M sh
Shares Diluted FY 2025 · Dec 31, 2024 84.82M sh
Capex FY 2025 · Dec 31, 2025 $618K
Capex FY 2025 · Dec 31, 2024 $1.03M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$68.26M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$90.5M
Cash And Equivalents FY 2025 · Dec 31, 2025 $100.55M
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.32M
Stockholders Equity FY 2025 · Dec 31, 2025 $123.27M
Stockholders Equity FY 2025 · Dec 31, 2024 $92.85M
Stockholders Equity FY 2025 · Dec 31, 2023 $139.42M
Current Liabilities FY 2025 · Dec 31, 2025 $15.44M
Current Liabilities FY 2025 · Dec 31, 2024 $15.98M
Total Liabilities FY 2025 · Dec 31, 2025 $23.66M
Total Liabilities FY 2025 · Dec 31, 2024 $27.09M
Current Assets FY 2025 · Dec 31, 2025 $105.59M
Current Assets FY 2025 · Dec 31, 2024 $67.38M
Total Assets FY 2025 · Dec 31, 2025 $146.92M
Total Assets FY 2025 · Dec 31, 2024 $119.94M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.59
Eps Diluted FY 2025 · Dec 31, 2024 −$1.31
Eps Basic FY 2025 · Dec 31, 2025 −$0.59
Eps Basic FY 2025 · Dec 31, 2024 −$1.31
Sga Expense FY 2025 · Dec 31, 2025 $24.72M
Sga Expense FY 2025 · Dec 31, 2024 $29.21M
Rd Expense FY 2025 · Dec 31, 2025 $68.61M
Rd Expense FY 2025 · Dec 31, 2024 $86.74M
Net Income FY 2025 · Dec 31, 2025 −$90.6M
Net Income FY 2025 · Dec 31, 2024 −$111.13M
Operating Income FY 2025 · Dec 31, 2025 −$93.33M
Operating Income FY 2025 · Dec 31, 2024 −$115.95M
Short Term Investments FY 2025 · Dec 31, 2024 $57.12M